Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AEON
AEON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AEON News
AEON Biopharma Holds FDA BPD Meeting, Secures $22 Million Financing
Jan 22 2026
NASDAQ.COM
AEON Biopharma Holds FDA BPD Meeting, Shareholders Approve PIPE Financing
Jan 21 2026
Newsfilter
AEON Biopharma Grants 392,158 RSUs to New Employees
Dec 19 2025
Globenewswire
AEON Biopharma Grants 392,158 Restricted Stock Units to New Employees
Dec 19 2025
Newsfilter
AEON and Daewoong Pharmaceutical Finalize $15 Million Debt Exchange Agreement
Dec 15 2025
Globenewswire
AEON and Daewoong Pharmaceutical Finalize $15 Million Debt Exchange Agreement
Dec 15 2025
Newsfilter
AEON Biopharma Completes First PIPE Closing, Raising Approximately $1.79 Million
Nov 24 2025
Newsfilter
Aegis Capital Affirms Buy Rating for AEON Biopharma, Keeps $7.2 Price Target Intact
Oct 08 2025
Benzinga
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
May 23 2025
Newsfilter
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025
May 19 2025
Newsfilter
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Apr 25 2025
Newsfilter
NYSE American accepts AEON Biopharma's plan to regain listing
Apr 25 2025
SeekingAlpha
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Apr 21 2025
Newsfilter
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer
Apr 21 2025
Newsfilter
AEON Biopharma Announces CEO Transition
Mar 27 2025
Newsfilter
AEON Biopharma GAAP EPS of $3.75
Mar 24 2025
SeekingAlpha
Show More News
